Health Condition 1: K590- Constipation
Conditions
Interventions
Intervention1: Athipazha Manappagu: The pediatric dosage of drug will be calculated using Clarks rule. The drug will be administered twice a day, after food, for 28 days
Control Intervention1: Nil: Ni
Sponsors
National Institute of Siddha
Eligibility
Inclusion criteria
Inclusion criteria: Clinical Symptoms: Children must exhibit a minimum of two or more of the following clinical symptoms occurring once per week for a duration of 1 month, in accordance with Rome IV criteria(children greater than 4 years) for functional constipation: a. 2 or fewer defecations in the toilet per week in a child of a developmental age at least 4 years. b. At least 1 episode of faecal incontinence per week. c. History of retentive posturing or excessive volitional stool retention. d. History of painful or hard bowel movements. e. Presence of large faecal mass in the rectum. f. History of large diameter stools that can obstruct the toilet.
Exclusion criteria
Exclusion criteria: Intolerable Stomach Pain Hirsch sprung Disease Rectal Prolapsed Congenital Hypothyroidism Duodenal Atresia Anorectal Malformations
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of the trial drug Athipazha Manappagu will be measured by reduction in clinical symptoms using Bristol Stool Scale. (Change in type from 1or 2 to type 3-5)Timepoint: 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The biochemical and physiochemical characteristics of the trial drug Athipazha manappagu will be analysedTimepoint: 18 months | — |
Countries
India
Contacts
Public ContactDr K Suresh
National Institute of Siddha
Outcome results
None listed